FIRST RESULTS OF THE DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL OF DIM-BASED THERAPY DESIGNED AS PERSONALIZED APPROACH TO REVERSE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) Статья Paltsev M., Kiselev V., Drukh V., Muyzhnek E., Kuznetsov I., Andrianova E., Baranovskiy P. EPMA Journal. BioMed Central Ltd.. Том 7. 2016.
DOUBLE-BLIND RANDOMIZED PLACEBOCONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION Статья Ashrafian L., Sukhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E. EPMA Journal. BioMed Central Ltd.. Том 6. 2015.
DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL (PHASE IIA) ON DIINDOLYLMETHANE'S EFFICACY AND SAFETY IN THE TREATMENT OF CIN: IMPLICATIONS FOR CERVICAL CANCER PREVENTION Статья Ashrafian L., Suhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E. EPMA Journal. BioMed Central Ltd.. Том Vol625. 2015.
SAFETY AND TOLERABILITY OF DIM-BASED THERAPY DESIGNED AS PERSONALIZED APPROACH TO REVERSE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) Статья Paltsev M., Kiselev V., Muyzhnek E., Drukh V., Kuznetsov I., Pchelintseva O. EPMA Journal. BioMed Central Ltd.. Том 5. 2014.